Related Experiment Video
Updated: Sep 9, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
The Dark Side of NK Cells in Cancer Immunotherapy
Felipe Galvez-Cancino1, Maria Armero1, David R Withers2
1Laboratory of Immune-Regulation, Centre for Immuno-Oncology, Nuffield Department of Medicine, Oxford, United Kingdom.
Abstract:
NK cells are a subset of innate lymphoid cells originally identified in mice and humans based on their ability to mediate cytotoxicity against transformed cells. However, two recent back-to-back studies in this issue of Cancer Discovery reveal that NK cell infiltration is not always beneficial; rather, it can impair the efficacy of immune checkpoint blockade through immune-regulatory mechanisms. See related article by Pozniak et al., p. 1819 See related article by Song et al., p. 1835.
Insights
Natural killer (NK) cells can hinder cancer immunotherapy. These immune cells, while cytotoxic, may impair the effectiveness of immune checkpoint blockade through regulatory mechanisms.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Biology
Background:
- Natural killer (NK) cells are innate lymphoid cells known for their cytotoxic activity against transformed cells in mice and humans.
- NK cell infiltration into tumors is a recognized phenomenon in cancer biology.
Purpose of the Study:
- To investigate the role of NK cell infiltration in the efficacy of immune checkpoint blockade therapies.
- To elucidate the immune-regulatory mechanisms by which NK cells may impact cancer treatment outcomes.
Main Methods:
- Analysis of NK cell infiltration in tumor microenvironments.
- Assessment of NK cell function in the context of immune checkpoint blockade.
- Investigation of immune-regulatory pathways involving NK cells.
Main Results:
- NK cell infiltration is not universally beneficial in cancer.
- Tumor-infiltrating NK cells can negatively regulate the anti-tumor immune response.
- NK cells can impair the efficacy of immune checkpoint blockade treatments.
Conclusions:
- The role of NK cells in cancer immunity is complex and context-dependent.
- NK cell infiltration can be detrimental to the success of immune checkpoint blockade.
- Targeting NK cell regulatory functions may represent a novel therapeutic strategy in oncology.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Tumor Immunotherapy
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...

